| Literature DB >> 10378690 |
A J Obaya1, M K Mateyak, J M Sedivy.
Abstract
A large body of physiological evidence shows that either upregulation or downregulation of intracellular c-Myc activity has profound consequences on cell cycle progression. Recent work suggests that c-Myc may stimulate the activity of cyclin E/cyclin-dependent kinase 2 (Cdk2) complexes and antagonize the action of the Cdk inhibitor p27KIP1. Cyclin D/Cdk4/6 complexes have also been implicated as targets of c-Myc activity. However, in spite of considerable effort, the mechanisms by which c-Myc interacts with the intrinsic cyclin/Cdk cell cycle machinery remain undefined.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10378690 DOI: 10.1038/sj.onc.1202749
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867